Teva Reports Loss

Teva Pharmaceutical Industries Ltd. (TEVA) attributed a first quarter loss of $1.01 per ADR compared with earnings of 38 cents per ADR to costs associated with its acquisition of Ivax Corp. Shares of the Israeli generic drug maker plunged $4.27 to $38.64.